Listed by the USPTO as WESTFALL, SARAH ANN
Tech Center 3700 • Art Units: 3791
This examiner grants 9% of resolved cases
WESTFALL, SARAH ANN has resolved 23 cases in art unit 3791 within tech center 3700. The allowance rate is 8.7%, the median time to allowance is 1270 days, and the interview lift is 33.3%. The limited record makes the figures directional, but the allowance result indicates that applicants should expect significant examination difficulty.
The leading companies are Seoul National University Hospital, The Regents of the University of Michigan, and DexCom Inc. The leading firms are ARENTFOX SCHIFF LLP - New York, Ascenda Law Group, PC, and BIRCH STEWART KOLASCH & BIRCH, LLP. Early interviews may help identify viable claim distinctions, but should accompany a robust written response.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18717359 | VASCULAR RESISTANCE AND BLOOD PRESSURE MEASUREMENT USING COMBINED PIEZOELECTRIC AND PHOTOPLETHYSMOGRAM MEASUREMENT | Final Rejection | REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 17974299 | Ranking Feedback For Improving Diabetes Management | Non-Final OA | DexCom, Inc. |
| 18601889 | PREDICTION OF USER CHARACTERISTICS USING SENSOR SIGNALS | Non-Final OA | QUALCOMM Incorporated |
| 17663350 | DETECTION OF INFECTION BASED ON TEMPERATURE AND IMPEDANCE | Final Rejection | Medtronic, Inc. |
| 18773900 | HEMODYNAMIC STATE ESTIMATION METHOD | Final Rejection | Murata Manufacturing Co., Ltd. |
| 17725063 | SYSTEMS AND METHODS FOR DIABETES MANAGEMENT | Final Rejection | ABBOTT DIABETES CARE INC. |
| 18538556 | FLUID INFUSION SYSTEMS | Final Rejection | Medtronic MiniMed, Inc. |
| 18047736 | ENDOLUMINAL VALVE PLACEMENT PATIENT OUTCOME PREDICTION | Non-Final OA | GYRUS ACMI, INC. D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA |
| 17782402 | URINE ANALYSIS DEVICES AND METHODS FOR REAL TIME MONITORING OF KIDNEY FUNCTION | Non-Final OA | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
| 18715680 | BRAIN WATER MONITORING METHOD AND APPARATUS BASED ON NEAR-INFRARED SPECTROSCOPY | Non-Final OA | SEOUL NATIONAL UNIVERSITY HOSPITAL |
| 18037191 | MEASURING AND IMPROVING ATTENTION | Final Rejection | Institució Catalana De Recerca I Estudis Avançats |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy8.7% of resolved applications examined by Sarah Ann Westfall were allowed (23 resolved cases), compared with 53.4% across Art Unit 3791 over the last five years.
This examiner's interview lift is +33.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Sarah Ann Westfall took 1,270 days on average from filing to allowance.
Sarah Ann Westfall examines applications in Art Unit 3791 in Tech Center 3700 (Medical Devices & Mechanical Engineering).